SOLVEAT

Company Overview

Snapshot

Founded in July 2020 by Zacki Nudelman, Udi Peretz, and Tal Naveh, SOLVEAT operates with 1–10 employees. The company has raised $1.6M across one funding round from two investors. In December 2021, SOLVEAT secured seed funding from The Trendlines Group and Israel Innovation Authority.

Business overview

SOLVEAT is a Food-Tech company focused on developing functional food solutions by integrating active herbal ingredients into everyday foods. Utilizing a proprietary technological platform, the company aims to create products that support specific health needs while maintaining taste and high scientific standards. SOLVEAT's initial product targets healthy blood sugar levels, with future developments planned for immunity, metabolic health, and other health concerns. The company operates within the Agriculture & Food Technologies sector, specifically in Novel Food & Ingredients, and serves the processed foods and ingredients markets globally.

Strategic signal

In September 2025, SOLVEAT announced a collaboration with CBC to develop botanical-enhanced functional soft drinks. This partnership signals a strategic expansion beyond its initial focus on solid food products and demonstrates the company's commitment to diversifying its product portfolio and market reach within the functional beverage sector, indicating potential for broader commercialization and market penetration.

Company Intelligence Q&A

What is SOLVEAT's core mission?

SOLVEAT aims to revolutionize everyday foods by integrating active herbal ingredients to address specific health needs, ensuring both delicious taste and high scientific standards.

When was SOLVEAT founded and by whom?

SOLVEAT was founded in July 2020 by Zacki Nudelman, Udi Peretz, and Tal Naveh.

What was a significant recent partnership for SOLVEAT?

In September 2025, SOLVEAT partnered with CBC to create botanical-enhanced functional soft drinks, expanding its product development into the beverage market.

What is SOLVEAT's primary product focus?

SOLVEAT's initial product helps maintain healthy blood sugar levels, with plans to develop solutions for immunity, metabolic health, and other high-impact health concerns.

What funding has SOLVEAT received?

SOLVEAT has raised $1.6M in total funding across one round. In December 2021, the company secured seed funding from The Trendlines Group and Israel Innovation Authority.